molybdenum dioxide

01/01/2022 - "NIR-II Responsive Molybdenum Dioxide Nanosystem Manipulating Cellular Immunogenicity for Enhanced Tumor Photoimmunotherapy."
01/01/2020 - "The therapeutic applications of MoO2 QDs open up a new avenue for tumor nanomedicine."
01/01/2018 - "These MoO2 nanoparticles possessed highly chemical stability and low toxicity with high PTT efficiency, thus promising them high potential as nanoagent in cancer treatment."
09/21/2017 - "The results prove that MoO2 NCs exhibiting NIR LSPR can act as an effective agent for photothermal cancer therapy with great photostability and biocompatibility."
01/01/2020 - "The strong NIR absorption endows MoO2 QDs with a high photothermal conversion efficiency of 66.3%, enabling broad prospects as a photo-responsive nanoagent for photothermal therapy of cancer. "

03/03/2021 - "CoMoO3 exhibited a notably improved reversible capacity of 860 mA h g-1, attributed to the conversion reaction, in contrast to MoO2 that delivers 310 mA h g-1, as it is limited by the insertion reaction. "
11/20/2020 - "However, intrinsic slow kinetics in bulk MoO2 severely restricts the redox conversion reaction. "
08/27/2014 - "The intercalation behavior of MoO2 is specially focused upon by limiting the charge-discharge cycling to narrow potential window of 1.0 to 2.2 V vs Li/Li(+) to avoid conversion reaction. "
10/01/2018 - "Reversible capacities of mesoporous MoO2 and CuO electrodes with well-developed nanostructures (1569 mA h g-1 for MoO2 and 1029 mA h g-1 for CuO) exceed their theoretical capacity based on the conversion reaction (838 mA h g-1 for MoO2 and 674 mA h g-1 for CuO). "
06/15/2021 - "Owing to the fact that [MoO2]2+ can be strongly chelated by phen, the molybdenum source in the MoO2(acac)(phen) precursor is highly dispersed, leading to the formation of ultra-small MoO2 nanoparticles in the nanocomposite, which can facilitate the conversion reaction. "

11/06/2019 - "In this study, semiconductor nanomaterials, that is, MoO2 nanoclusters, were synthesized and used for the first time in PTT for inflammatory Mφ-mediated atherosclerosis. "

12/29/2021 - "In this study, single-site Mo(═O)2 species grafted onto reduced graphene oxide (rGO/MoO2) are characterized by XPS, DRIFTS, powder XRD, N2 physisorption, NH3-TPD, aqueous contact angle, active site poisoning assay, Mo EXAFS, model compound single-crystal XRD, DFT, and catalytic performance. "

12/27/2022 - "In this study, we report a microwave (MW)-responsive MoO2/WO3 heterojunction that can be utilized to effectively treat MRSA-infected osteomyelitis under MW irradiation because of the enhanced MW thermal effect and MW catalysis of the composite. "
12/27/2022 - "Interfacial Mo, W-Conjugated Polarization, and Oxygen Vacancies of MoO2/WO3 in Enhanced Microwave Therapy for MRSA-Induced Osteomyelitis."